The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage study L Degenhardt, S Larney, J Kimber, N Gisev, M Farrell, T Dobbins, ... Addiction 109 (8), 1306-1317, 2014 | 269 | 2014 |
Exposure to opioid maintenance treatment reduces long‐term mortality A Gibson, L Degenhardt, RP Mattick, R Ali, J White, S O'Brien Addiction 103 (3), 462-468, 2008 | 262 | 2008 |
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial AE Gibson, CM Doran, JR Bell, A Ryan, N Lintzeris Medical Journal of Australia 179 (1), 38-42, 2003 | 114 | 2003 |
The increasing mortality burden of liver disease among opioid‐dependent people: cohort study A Gibson, D Randall, L Degenhardt Addiction 106 (12), 2186-2192, 2011 | 101 | 2011 |
Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study S Larney, N Gisev, M Farrell, T Dobbins, L Burns, A Gibson, J Kimber, ... BMJ open 4 (4), e004666, 2014 | 99 | 2014 |
A pilot study of buprenorphine—naloxone combination tablet (Suboxone®) in treatment of opioid dependence J Bell, G Byron, A Gibson, A Morris Drug and Alcohol Review 23 (3), 311-317, 2004 | 87 | 2004 |
Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records AE Gibson, LJ Degenhardt Drug and alcohol review 26 (4), 405-410, 2007 | 86 | 2007 |
A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia L Burns, N Gisev, S Larney, T Dobbins, A Gibson, J Kimber, B Larance, ... Addiction 110 (4), 646-655, 2015 | 84 | 2015 |
Opioid overdose deaths can occur in patients with naltrexone implants AE Gibson, LJ Degenhardt, WD Hall Medical Journal of Australia 187 (1), 56-57, 2007 | 53 | 2007 |
Compliance with telephone triage advice among adults aged 45 years and older: an Australian data linkage study DT Tran, A Gibson, D Randall, A Havard, M Byrne, M Robinson, A Lawler, ... BMC health services research 17, 1-13, 2017 | 39 | 2017 |
Global and Australian heroin markets A Gibson, L Degenhardt, L Topp, C Day, W Hall, P Dietze, R McKetin Sydney, National Drug and Alcohol Research Centre, University of New South Wales, 2003 | 38 | 2003 |
Mortality among people who use illicit drugs: A toolkit for classifying major causes of death D Randall, A Roxburgh, A Gibson, L Degenhardt | 37 | 2009 |
Emergency department attendance after telephone triage: a population‐based data linkage study A Gibson, D Randall, DT Tran, M Byrne, A Lawler, A Havard, M Robinson, ... Health services research 53 (2), 1137-1162, 2018 | 31 | 2018 |
The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people S Larney, D Randall, A Gibson, L Degenhardt Drug and alcohol dependence 131 (3), 252-257, 2013 | 31 | 2013 |
Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy L Degenhardt, A Gibson, RP Mattick, W Hall Drug and alcohol review 27 (1), 1-3, 2008 | 28 | 2008 |
Recent trends in heroin supply to markets in Australia, the United States and Western Europe A Gibson, L Degenhardt, C Day, R McKetin International Journal of Drug Policy 16 (5), 293-299, 2005 | 28 | 2005 |
Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and … N Gisev, A Gibson, S Larney, J Kimber, M Williams, A Clifford, M Doyle, ... BMC Public Health 14, 1-16, 2014 | 20 | 2014 |
Follow-up difficulty: correlates and relationship with outcome in heroin dependence treatment in the NEPOD study E Digiusto, M Panjari, A Gibson, F Rea, NEPOD Research Group Addictive behaviors 31 (7), 1201-1210, 2006 | 19 | 2006 |
Mortality related to naltrexone in the treatment of opioid dependence: a comparative analysis A Gibson, L Degenhardt National Drug and Alcohol Research Centre, University of New South Wales, 2005 | 17 | 2005 |
A cost‐effectiveness analysis of buprenorphine‐assisted heroin withdrawal CM Doran, M Shanahan, J Bell, A Gibson Drug and Alcohol Review 23 (2), 171-175, 2004 | 17 | 2004 |